1 vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention-Reply

JAMA. 2019 Nov 5;322(17):1715-1716. doi: 10.1001/jama.2019.14250.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clopidogrel
  • Hemorrhage
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors
  • Ticlopidine

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine